A medication price is useful only when you know what purchase it describes. The Pharmacy Place advertises semaglutide starting at $139 per month and tirzepatide starting at $179 per month, without membership fees or minimum commitments. That sounds straightforward, but its product pages complicate the comparison: tirzepatide reaches a higher advertised maximum there, and semaglutide options do not all describe the same supply period. For someone budgeting out of pocket, the central question is not simply whether the starting price is affordable. It is what the first payment buys and what the next order will cost.
The Pharmacy Place presents itself as a compounding pharmacy in Peachtree City, Georgia, preparing medication in-house and coordinating a telemedicine assessment. This review examines its documented offerings and payment structure using sources consulted October 19, 2026. The strongest pricing feature is the stated inclusion of consultation, injection supplies and shipping. The principal limitations are inconsistent tirzepatide price ceilings, incomplete renewal and refund terms, and no comprehensive state availability list. These gaps do not establish improper billing, but they make a written, product-specific quote more useful than the headline monthly figure.
At a glance
- Advertised monthly prices
- The program page lists semaglutide from $139 to $179 per month depending on dose, and tirzepatide from $179 to $279 per month.Sources: [9]
- Product-page discrepancy
- The tirzepatide listing shows $179–$299, with no supply period established by that price heading; its maximum exceeds the program page's $279 monthly maximum.
- Included charges
- Product listings include a physician consultation valued at $20, free shipping and injection supplies. The pharmacy also advertises no membership fees or minimum commitments.
- Payment precedes the questionnaire
- Product pages say a secure medical-questionnaire link follows checkout. Prescription issuance and pharmacy processing remain subject to clinical approval.Sources: [7]
Start with the purchase, not the monthly headline
The program page gives two explicit monthly ranges: compounded injectable semaglutide starts at $139 and rises to $179 depending on dose; compounded injectable tirzepatide starts at $179 and rises to $279. These are starting-at offers, not promises that every patient can purchase either medicine at the lowest price. The program describes injections under the skin and says patients will be taught preparation and administration. Its general formulation description also says the compounded injections contain B vitamins, without establishing the precise vitamin composition for each product.
The semaglutide product listing repeats a $139–$179 range. The tirzepatide listing instead shows $179–$299. That $299 ceiling should not be silently replaced by the lower program-page figure, nor treated as a confirmed monthly charge: the quoted product heading does not establish its supply period. Ask which listing applies to the prescribed formulation and selected presentation, how much medication that purchase supplies, and the final checkout amount. The pharmacy's terms acknowledge that website materials may contain errors and may not be current.
The comparison below preserves those distinctions rather than choosing one page as definitive. There is no documented introductory discount followed by a specified renewal schedule in the consulted material. A useful first-payment comparison therefore starts with the selected product and supply period, not an assumption that the advertised minimum will be the first or recurring charge.
| Offer or listing | Published amount | Condition to preserve |
|---|---|---|
| Semaglutide program page | Starts at $139/month; up to $179/month | Dose-dependent monthly advertising |
| Semaglutide product page | $139–$179 | Selected presentation and supply period need confirmation |
| Tirzepatide program page | Starts at $179/month; up to $279/month | Monthly program-page range |
| Tirzepatide product page | $179–$299 | Higher ceiling; price heading does not establish supply period |
| Consultation on product listings | $20 value included | Not presented as an additional $20 checkout fee |
Included services make the price more informative
The product pages explicitly include a physician consultation, described as having a $20 value, in the listed price. They also include shipping and all injection supplies. The program page similarly advertises no membership, consultation or shipping fees and no other hidden fees. Read together, these statements support an advertised bundled purchase rather than a medication price that automatically requires a separate $20 consultation payment. They do not, however, provide a complete schedule of every possible future clinical service.
The pharmacy's homepage goes further on commitment: it advertises no memberships, no minimums and no commitments, with payment only for medication. That is a meaningful distinction from an offer requiring a separate recurring access fee. Still, it does not explain whether subsequent orders are patient-initiated, automatically charged or linked to a prescription-renewal process. The consulted documentation does not establish recurring billing terms, multi-month prepayment requirements or optional installment arrangements.
For budgeting, separate documented inclusions from assumptions about ongoing care. Initial consultation, injection materials and shipping are expressly included; a defined schedule of repeat clinician evaluations is not. Pharmacy support is advertised, but that should not be converted into a promise of unlimited physician visits. Our guide to what a program price includes offers a useful framework for asking the pharmacy to identify both bundled services and any separately priced follow-up before payment.
Supply periods and later purchases remain separate questions
The semaglutide product material distinguishes an initial six-week supply from other four-week options. That matters even though the general advertising uses monthly prices. Four weeks is not a calendar month, and a six-week initial presentation is not evidence that every subsequent purchase lasts six weeks. The available documentation does not support assigning the lowest listed price to every presentation or treating every purchase as an identical monthly refill. Confirm the specific option attached to the displayed amount before comparing it with another service.
Nor does a supply description establish a minimum commitment. A six-week option describes a presentation, not necessarily a contract requiring future purchases. Conversely, the absence of a membership does not itself explain when the next payment becomes due. Ask for the expected reorder interval, whether any payment authorization repeats, and how a changed prescription affects the next price. The site's dose-dependent semaglutide range signals that at least some pricing varies, but it does not provide a complete personalized renewal quote.
This is where monthly and four-week billing distinctions become practical rather than semantic. A useful written estimate would identify the medicine, formulation, presentation, covered supply period and charge for that purchase, followed separately by the process for later orders. Without those details, annualizing a starting price would create false precision. No annual total or savings estimate is warranted from these published ranges, and no documented appointment window establishes a price lock.
Checkout starts a clinical process, not a guaranteed prescription
The product pages describe checkout first, followed by a secure link to a medical questionnaire. The pharmacy asks patients to complete it promptly to avoid delays. The program page says the form covers health, lifestyle and medical history, after which a licensed physician reviews the information and, if appropriate, prescribes. Prescription issuance and pharmacy processing are explicitly conditional on approval. A payment therefore should not be read as proof that treatment has been authorized or that the buyer will necessarily receive either advertised medicine.
The Pharmacy Place says its telehealth platform coordinates prescribing with a provider specializing in weight management. It does not identify the external clinical entity or individual reviewing physicians in the consulted material. The published eligibility description is adults 18 or older who are not pregnant or breastfeeding and do not have certain conditions that would make treatment unsafe. Specific excluded conditions, laboratory requirements and complete clinical criteria are not established here; readers should not substitute general medication criteria for this provider's actual assessment.
The cost consequence of this sequence is the unresolved handling of payment if clinical approval does not follow checkout. The available documentation does not specify whether the entire amount is refunded, whether any assessment charge is retained, or when a refund would be processed. Settle that question before paying. Equally, ask who handles requests for more information and whether extra evaluation could generate a separate charge, rather than assuming the initial advertised bundle answers every possible clinical contingency.
Shipping is included, but delivery stages still matter
The advertised shipping method is UPS Next-Day in temperature-controlled packaging, with administration supplies such as syringes and alcohol swabs included. Product listings promise a processing notification and tracking information once the order ships. These details help explain what the bundled price buys, but Next-Day shipping describes a transport service after dispatch. It does not mean medication arrives the day after checkout, before clinical review, prescription transmission and pharmacy preparation have taken place.
The timing statements describe different stages. The homepage says most orders ship within one to two business days after prescription approval. The program page says physicians typically send prescriptions within one to two days of the consultation; prescriptions received in the morning usually ship that day, while afternoon receipts ship the following business day. It also claims most patients receive medication within 72 hours of consultation. These are provider estimates, not a single guaranteed timeline, and should not be combined into a promised arrival date.
For lost or delayed packages, the pharmacy instructs patients to contact it immediately. The documentation does not clearly establish replacement charges or reimbursement responsibilities. A temperature-controlled package also does not establish that a particular shipment remained adequately refrigerated. FDA explicitly advises not using an injectable GLP-1 drug that arrives warm or with insufficient refrigeration and contacting the provider or dispensing pharmacy. That safety instruction takes priority over treating a shipment as acceptable merely because expedited shipping was included in its price.
No minimum commitment is not a refund policy
The clearest documented post-purchase boundary is that the pharmacy cannot accept medication back once it has left its facilities. That is a return restriction, not a comprehensive statement about refunds. It does not answer what happens after clinical denial, cancellation before dispatch, a missing shipment or a quality concern. Similarly, advertising no commitments does not establish that an order already being prepared can be canceled without cost. These are separate questions about future purchasing obligations and money already collected.
Before checkout, request a written explanation of when an order becomes noncancelable and how the pharmacy handles each of those situations. If a refund is available, ask how it is requested, what portion is refundable and when it is processed; processing does not necessarily mean funds reach a bank account that day. The consulted sources do not establish a cancellation notice deadline, refund timeline or automatic-renewal cancellation procedure. It would be misleading to invent those details or to interpret silence as a guaranteed refund.
Communication preferences are better documented. The privacy policy says marketing consent is not required to purchase, and patients can withdraw it. SMS recipients can reply STOP, although administrative communications may continue. Opting out of marketing is not the same as canceling medication or reversing payment. Our discussion of cancellation and refund boundaries can help distinguish those actions when asking the pharmacy for an order-specific explanation.
Confirm the state and the people responsible for support
The Pharmacy Place lists its address as 2035 Commerce Dr N, Peachtree City, GA 30269, with general telephone number 678-271-3970. Its program page separately provides 833-586-3111 for questions and says a pharmacist is on staff to help. The homepage identifies Hiren Patel as founder, pharmacist and owner. The published team also includes Charley Nowicki as clinical pharmacist liaison, Tiffany Turner as pharmacist and Neil Patel as compounding lead technician.
These named roles make the business more identifiable, but they are not independent verification of licensure or proof of a particular clinical follow-up arrangement. The pharmacy describes itself as fully licensed, says it compounds in-house and claims LegitScript certification. Those remain attributed business claims in this review. Its pharmacy team advertises ongoing support, while the consulted material does not define scheduled clinician visits, response-time guarantees, support hours, interpretation services or prescription-renewal responsibilities.
Geographic access should be settled before payment. The homepage says the business currently serves the Southeast and plans nationwide expansion. Another page says it is licensed in multiple states and asks patients to contact it about their own state. Those statements do not establish nationwide availability or a complete list of destinations. A practical inquiry should confirm both prescribing and pharmacy service for the delivery address, then identify whom to contact for clinical questions, order changes and shipment problems.
Evaluate the cash price without confusing it with clinical evidence
The program is explicitly cash-pay and says insurance is not needed. That establishes its advertised payment model, not reimbursement eligibility through a patient's plan. The sources do not clarify whether the pharmacy provides documentation for insurance reimbursement or healthcare spending accounts. NIDDK notes that insurance coverage for weight-management medication varies by plan. Anyone hoping to offset this purchase should confirm both the pharmacy's documentation and the plan's requirements rather than treating a direct-pay receipt as a promise of coverage.
The pharmacy acknowledges that compounded medications are not FDA approved or evaluated by FDA for safety, effectiveness or quality. FDA approval belongs to specific products, not to a pharmacy or telehealth program. FDA recommends compounded drugs when an individual's medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Nonapproval alone does not demonstrate clinical inequivalence, but neither a lower price nor claimed in-house preparation establishes equivalence to an approved product.
The site's B-vitamin claims about energy and metabolism are commercial statements, not independent evidence of benefit from its particular preparations. Published drug-trial results should not be treated as measured results for this pharmacy or its blends. For ongoing budgeting, NIDDK emphasizes that treatment duration depends on response and side effects and that follow-up concerns more than renewed payments. The unanswered question is therefore not just the next medication charge, but how clinical reassessment is arranged and what, if anything, it costs.
Questions & answers
What should I budget for The Pharmacy Place's tirzepatide?
The program advertises compounded injectable tirzepatide starting at $179 per month and reaching $279 per month. Its product listing instead shows $179–$299 without establishing a supply period in the price heading. Neither figure is a personalized quote. Before paying, obtain the selected formulation, presentation, supply period and final charge in writing, including which published maximum applies.
Is the $20 doctor consultation an additional charge?
The semaglutide and tirzepatide product listings describe the $20 consultation value as included in the product price. They also list free shipping and injection supplies. The program page advertises no consultation fee. Those statements do not establish the price of every future clinical visit, so ask separately about reassessments, prescription renewals and any services outside the initial purchase.
Will the pharmacy charge me before deciding whether to prescribe?
The product-page sequence places checkout before delivery of the secure questionnaire link. Clinical approval still determines whether a prescription is issued and processing begins. The consulted sources do not explain the refund outcome if approval is denied. Ask how payment is handled in that situation before completing checkout; purchasing does not guarantee a prescription.
Does no membership mean I can return an unwanted order?
No. The pharmacy advertises no membership, minimum or commitment, but separately states that medication cannot be returned once it has left the pharmacy. That return restriction does not define every possible refund outcome. Obtain the cancellation cutoff and financial terms before ordering, particularly for an order already being prepared or shipped.
Can The Pharmacy Place ship to any U.S. state?
Nationwide service is not established by the consulted sources. The homepage describes current service throughout the Southeast and nationwide expansion as a future plan. The pharmacy also says it is licensed in multiple states and asks patients to contact it for state-specific confirmation. Use 678-271-3970 or the program number, 833-586-3111, to verify availability before checkout.
What if my included shipment is late or arrives warm?
The pharmacy says to contact it immediately about a lost or delayed package. Its advertised UPS Next-Day service follows preparation and dispatch, not checkout. FDA advises not using injectable GLP-1 medication that arrives warm or inadequately refrigerated and contacting the provider or dispensing pharmacy. Replacement and refund responsibilities are not clearly established in the consulted pharmacy documentation.
Our assessment
The Pharmacy Place documents a comparatively simple advertised cost structure: cash-pay compounded injections, consultation and supplies included, free shipping, and no membership or minimum commitment. It also identifies a physical pharmacy and offers direct telephone access. Those are useful purchasing details, not proof of clinical outcomes or independently verified credentials. The main budgeting weaknesses are the conflicting tirzepatide ceilings, differing semaglutide supply periods, and incomplete explanations of later billing, clinical follow-up and refunds. A reasonable next step is a written quote confirming state availability, exact product and supply period, total charge, reorder process and what happens if clinical approval or delivery fails. Until those answers are supplied, the advertised minimum is best treated as an entry price—not a complete care budget.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- NIDDK: prescription medications for overweight and obesity ↗
- The Pharmacy Place — privacy policy ↗
- The Pharmacy Place — product/tirzepatide ↗
- The Pharmacy Place — about us ↗
- The Pharmacy Place — terms and conditions ↗
- The Pharmacy Place — product/semaglutide ↗
- The Pharmacy Place — official website ↗
- The Pharmacy Place — glp1 weight loss injections ↗